{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:38:16Z","timestamp":1772638696421,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40199-021-00408-6","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T06:03:58Z","timestamp":1629439438000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors"],"prefix":"10.1007","volume":"29","author":[{"given":"Yukeswaran","family":"Loganathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-8411","authenticated-orcid":false,"given":"Manav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashini","family":"Thiyagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreeranjana","family":"Shanmuganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh Kumar","family":"Mariappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-0047","authenticated-orcid":false,"given":"Moni Philip Jacob","family":"Kizhakedathil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-2460","authenticated-orcid":false,"given":"Tamilselvi","family":"Saravanakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"issue":"12","key":"408_CR1","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1080\/07391102.2019.1664328","volume":"38","author":"T Joshi","year":"2020","unstructured":"Joshi T, Sharma P, Joshi T, Chandra S. In silico screening of anti-inflammatory compounds from Lichen by targeting cyclooxygenase-2. J Biomol Struct Dyn. 2020;38(12):3544\u201362. https:\/\/doi.org\/10.1080\/07391102.2019.1664328.","journal-title":"J Biomol Struct Dyn"},{"key":"408_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01630479","volume":"44","author":"JR Vane","year":"1995","unstructured":"Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res. 1995;44:1\u201310. https:\/\/doi.org\/10.1007\/BF01630479.","journal-title":"Inflamm Res"},{"issue":"1","key":"408_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/2152-7806.73804","volume":"2010","author":"J Bost","year":"2010","unstructured":"Bost J, Maroon A, Maroon J. Natural anti-inflammatory agents for pain relief. Surg Neurol Int. 2010;2010(1):80. https:\/\/doi.org\/10.4103\/2152-7806.73804.","journal-title":"Surg Neurol Int"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/07391102.2008.10507200","volume":"25","author":"V Rajakrishnan","year":"2008","unstructured":"Rajakrishnan V, Manoj VR, Rao GS. Computer-aided, rational design of a potent and selective small peptide inhibitor of cyclooxygenase 2 (cox2). J Biomol Struct Dyn. 2008;25:535\u201342. https:\/\/doi.org\/10.1080\/07391102.2008.10507200.","journal-title":"J Biomol Struct Dyn"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1073\/pnas.89.16.7384","volume":"89","author":"T Hla","year":"1992","unstructured":"Hla T, Neilson K. Human cyclooxygenase-2 cDNA. ProcNatl Acad Sci USA. 1992;89:7384\u20138. https:\/\/doi.org\/10.1073\/pnas.89.16.7384.","journal-title":"ProcNatl Acad Sci USA"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-73203-z","volume":"10","author":"F das Chagas Pereira de Andrade","year":"2020","unstructured":"das Chagas Pereira de Andrade F, Mendes AN. Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways. Sci Rep. 2020;10:1\u201314. https:\/\/doi.org\/10.1038\/s41598-020-73203-z.","journal-title":"Sci Rep"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3810\/pgm.1999.10.1.704","volume":"106","author":"Q Rehman","year":"1999","unstructured":"Rehman Q, Sack KE. When to try COX-2-specific inhibitors: Safer than standard NSAIDs in some situations. Postgrad Med. 1999;106:95\u2013106. https:\/\/doi.org\/10.3810\/pgm.1999.10.1.704.","journal-title":"Postgrad Med"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/367243a0","volume":"367","author":"D Picot","year":"1994","unstructured":"Picot D, Loll PJ, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H 2 synthase-1. Nature. 1994;367:243\u20139. https:\/\/doi.org\/10.1038\/367243a0.","journal-title":"Nature"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"23261","DOI":"10.1016\/s0021-9258(18)54491-4","volume":"266","author":"MK O\u2019Banion","year":"1991","unstructured":"O\u2019Banion MK, Sadowski HB, Winn V, Young DA. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem. 1991;266:23261\u20137. https:\/\/doi.org\/10.1016\/s0021-9258(18)54491-4.","journal-title":"J Biol Chem"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines6040107","volume":"6","author":"KDPP Gunathilake","year":"2018","unstructured":"Gunathilake KDPP, Ranaweera KKDS, Rupasinghe HPV. In vitro anti-inflammatory properties of selected green leafy vegetables. Biomedicines. 2018;6:1\u201310. https:\/\/doi.org\/10.3390\/biomedicines6040107.","journal-title":"Biomedicines"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0009-9236(99)70113-X","volume":"65","author":"EW Ehrich","year":"1999","unstructured":"Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, Porras A, Wittreich J, Seibold JR, De Schepper P, Mehlisch DR, Gertz BJ. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther. 1999;65:336\u201347. https:\/\/doi.org\/10.1016\/S0009-9236(99)70113-X.","journal-title":"Clin Pharmacol Ther"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/14656566.2.1.31","volume":"2","author":"A Ballinger","year":"2001","unstructured":"Ballinger A, Smith G. COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention. Expert Opin Pharmacother. 2001;2:31\u201340. https:\/\/doi.org\/10.1517\/14656566.2.1.31.","journal-title":"Expert Opin Pharmacother"},{"key":"408_CR13","first-page":"99","volume":"2","author":"T Rajkumar","year":"2010","unstructured":"Rajkumar T, Kumar ES, Sinha BN. Evaluation ofantioxidant properties of Albizia amara leaves. Int J Adv PharmBiolSci. 2010;2:99\u2013106.","journal-title":"Int J Adv PharmBiolSci"},{"key":"408_CR14","first-page":"70","volume":"5","author":"K Kokila","year":"2013","unstructured":"Kokila K, Priyadharshini SD, Sujatha V. Phytopharmacological properties of Albizia species: A review. Int J Pharm Pharm Sci. 2013;5:70\u20133.","journal-title":"Int J Pharm Pharm Sci"},{"key":"408_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7897\/2230-8407.0811213","volume":"8","author":"S Nivetha","year":"2017","unstructured":"Nivetha S, Padmini S, Tamilselvi S. A Review on Phytopharmacological Properties of Arappu. Int Res J Pharm. 2017;8:28\u201332. https:\/\/doi.org\/10.7897\/2230-8407.0811213.","journal-title":"Int Res J Pharm"},{"key":"408_CR16","first-page":"621","volume":"5","author":"G Indravathi","year":"2016","unstructured":"Indravathi G, Reddy RS, Babu PS. Albizia amara - A Potential Medicinal Plant: A Review. Int J Sci Res. 2016;5:621\u20137.","journal-title":"Int J Sci Res"},{"key":"408_CR17","first-page":"48","volume":"2","author":"M Jabeen","year":"2012","unstructured":"Jabeen M, Jillani U, Chaudhary BA, Uzair M. Phytochemical and pharmacological studies of Phyla Nodiflora(Verbenaceae): A review. Pak J Pharm Sci. 2012;2:48\u201354.","journal-title":"Pak J Pharm Sci"},{"key":"408_CR18","first-page":"57","volume":"20","author":"RA Sharma","year":"2013","unstructured":"Sharma RA, Singh R. A Review on Phyla nodifloraLinn.: A wild wetland medicinal herb. Int J Pharm Sci Rev Res. 2013;20:57\u201363.","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"8","key":"408_CR19","first-page":"15","volume":"9","author":"AE Al-Snafi","year":"2019","unstructured":"Al-Snafi AE. Pharmacological and therapeutic effects of Lippia nodiflora (Phyla nodiflora). IOSR J Pharm. 2019;9(8):15\u201325.","journal-title":"IOSR J Pharm"},{"key":"408_CR20","first-page":"466","volume":"7","author":"S Tamilselvi","year":"2019","unstructured":"Tamilselvi S, Dharani T, Padmini S, Nivetha S, Sangeetha M, Das A, Balakrishnaraja R. GC-MS analysis of Albizia amara and Phyla nodiflora ethanolic leaf extracts. Int J Recent Technol Eng. 2019;7:466\u201373.","journal-title":"Int J Recent Technol Eng"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemicaleditor, visualization, and analysis platform. J Cheminformatics. 2012;4:1\u201317.","journal-title":"J Cheminformatics"},{"key":"408_CR22","first-page":"1","volume-title":"Biomolecular Simulation: The GROMOS96 Manual and User Guide","author":"WF van Gunsteren","year":"1996","unstructured":"van Gunsteren WF, Billeter SR, Eising AA, H\u00fcnenberger PH, Kr\u00fcger P, Mark AE, Scott WRP, Tironi IG. Biomolecular Simulation: The GROMOS96 Manual and User Guide. Z\u00fcrich: Vdf Hochschulverlag AG an der ETH; 1996. p. 1\u20131042."},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361. https:\/\/doi.org\/10.1002\/jcc.21334.","journal-title":"J Comput Chem"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46:W363\u20137. https:\/\/doi.org\/10.1093\/nar\/gky473.","journal-title":"Nucleic Acids Res"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ, Adasme MF, Schroeder M. PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Res. 2015;43:W443\u20137. https:\/\/doi.org\/10.1093\/nar\/gkv315.","journal-title":"Nucleic Acids Res"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778\u201386.","journal-title":"J Chem Inf Model"},{"issue":"7","key":"408_CR27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s12039-016-1103-3","volume":"128","author":"R Bathini","year":"2016","unstructured":"Bathini R, Sivan SK, Fatima S, Manga V. Molecular docking, MM\/GBSA and 3D-QSAR studies on EGFR inhibitors. J Chem Sci. 2016;128(7):1163\u201373.","journal-title":"J Chem Sci"},{"issue":"14","key":"408_CR28","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","volume":"17","author":"X Zhang","year":"2017","unstructured":"Zhang X, Perez-Sanchez H, Lightstone F. A comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr Top Med Chem. 2017;17(14):1631\u20139.","journal-title":"Curr Top Med Chem"},{"issue":"W1","key":"408_CR29","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257\u201363. https:\/\/doi.org\/10.1093\/nar\/gky318.","journal-title":"Nucleic Acids Res"},{"key":"408_CR30","unstructured":"Schr\u00f6dinger Release. Desmond molecular dynamics system. Maestro-Desmond interoperability tools. New York: D. E. Shaw Research; 2019."},{"key":"408_CR31","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc. 1996;118:11225\u201336. https:\/\/doi.org\/10.1021\/ja9621760.","journal-title":"J Am Chem Soc"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jpha.2017.07.006","volume":"8","author":"S Vijayakumar","year":"2018","unstructured":"Vijayakumar S, Manogar P, Prabhu S, Singh RAS. Novel ligand-based docking; molecular dynamic Simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer\u2019s disease. J Pharm Anal. 2018;8:413\u201320. https:\/\/doi.org\/10.1016\/j.jpha.2017.07.006.","journal-title":"J Pharm Anal"},{"key":"408_CR33","first-page":"655","volume":"10","author":"A Zarghi","year":"2011","unstructured":"Zarghi A, Arfaei S. Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships. Iran J Pharm Res. 2011;10:655\u201383.","journal-title":"Iran J Pharm Res"},{"key":"408_CR34","doi-asserted-by":"publisher","unstructured":"Prabhavathi H, Dasegowda KR, Renukananda KH, Lingaraju K, Naika HR. Exploration and evaluation of bioactive phytocompounds against BRCA proteins by in silico approach. J Biomol Struct Dyn. 2020; 1\u201315.\u00a0https:\/\/doi.org\/10.1080\/07391102.2020.1790424","DOI":"10.1080\/07391102.2020.1790424"},{"key":"408_CR35","doi-asserted-by":"publisher","unstructured":"Daze K, Hof F. Molecular interaction and recognition. In Encyclopedia of physical organic chemistry. Vol 5. Wiley; 2016.\u00a0https:\/\/doi.org\/10.1002\/9781118468586.epoc3001","DOI":"10.1002\/9781118468586.epoc3001"},{"issue":"1982","key":"408_CR36","first-page":"37","volume":"1","author":"Panel, CIR Expert, Cosmetic Ingredient Review Expert Panel","year":"1982","unstructured":"Panel, CIR Expert, Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of squalane and squalene. J Am Coll Toxicol. 1982;1(1982):37\u201356.","journal-title":"J Am Coll Toxicol"},{"issue":"1","key":"408_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/molecules14010540","volume":"14","author":"ZR Huang","year":"2009","unstructured":"Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 2009;14(1):540\u201354.","journal-title":"Molecules"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijbiomac.2016.10.040","volume":"94","author":"T Pandey","year":"2017","unstructured":"Pandey T, Shukla R, Shukla H, Sonkar A, Tripathi T, Singh AK. A combined biochemical and computational studies of the rho-class glutathione s-transferase sll1545 of Synechocystis PCC 6803. Int J Biol Macromol. 2017;94:378\u201385. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.10.040.","journal-title":"Int J Biol Macromol"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1080\/07391102.2017.1341337","volume":"36","author":"R Shukla","year":"2018","unstructured":"Shukla R, Shukla H, Sonkar A, Pandey T, Tripathi T. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase. J Biomol Struct Dyn. 2018;36:2045\u201357. https:\/\/doi.org\/10.1080\/07391102.2017.1341337.","journal-title":"J Biomol Struct Dyn"},{"key":"408_CR40","doi-asserted-by":"publisher","unstructured":"ul Hassan SS, Zhang WD, Jin H, Basha SH, Priya SVSS. In-silico anti-inflammatory potential of guaiane dimers from\u00a0Xylopia vielana\u00a0targeting COX-2. J Biomol Struct Dyn. 2020; 1\u201315.\u00a0https:\/\/doi.org\/10.1080\/07391102.2020.1815579","DOI":"10.1080\/07391102.2020.1815579"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-021-00408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-021-00408-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-021-00408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:10:26Z","timestamp":1637237426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-021-00408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s40199-021-00408-6","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}